Record Date

Gland Pharma has announced a board meeting on August 14, 2025, as the record date for final dividend eligibility of ₹18 per share for FY25, pending approval at the 47th AGM on August 28, 2025. The company posted consolidated revenue of ₹561.65 billion for FY25, down 1% YoY, with PAT at ₹69.85 billion, down 10% YoY.

Stable margins were supported by new US product launches and strong R&D focus.